Literature DB >> 9190803

In vivo and in vitro effects of thiolactomycin on fatty acid biosynthesis in Streptomyces collinus.

K K Wallace1, S Lobo, L Han, H A McArthur, K A Reynolds.   

Abstract

A stable-isotope assay was used to analyze the effectiveness of various perdeuterated short-chain acyl coenzyme A (acyl-CoA) compounds as starter units for straight- and branched-chain fatty acid biosynthesis in cell extracts of Streptomyces collinus. In these extracts perdeuterated isobutyryl-CoA was converted to isopalmitate (a branched-chain fatty acid), while butyryl-CoA was converted to palmitate (a straight-chain fatty acid). These observations are consistent with previous in vivo analyses of fatty acid biosynthesis in S. collinus, which suggested that butyryl-CoA and isobutyryl-CoA function as starter units for palmitate and isopalmitate biosynthesis, respectively. Additionally, in vitro analysis demonstrated that acetyl-CoA can function as a starter unit for palmitate biosynthesis. Palmitate biosynthesis and isopalmitate biosynthesis in these cell extracts were both effectively inhibited by thiolactomycin, a known type II fatty acid synthase inhibitor. In vivo experiments demonstrated that concentrations of thiolactomycin ranging from 0.1 to 0.2 mg/ml produced both a dramatic decrease in the cellular levels of branched-chain fatty acids and a surprising three- to fivefold increase in the cellular levels of the straight-chain fatty acids palmitate and myristate. Additional in vivo incorporation studies with perdeuterated butyrate suggested that, in accord with the in vitro studies, the biosynthesis of the palmitate from butyryl-CoA decreases in the presence of thiolactomycin. In contrast, in vivo incorporation studies with perdeuterated acetate demonstrated that the biosynthesis of palmitate from acetyl-CoA increases in the presence of thiolactomycin. These observations clearly demonstrate that isobutyryl-CoA is a starter unit for isopalmitate biosynthesis and that either acetyl-CoA or butyryl-CoA can be a starter unit for palmitate biosynthesis in S. collinus. However, the pathway for palmitate biosynthesis from acetyl-CoA is less sensitive to thiolactomycin, and it is suggested that the basis for this difference is in the initiation step.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190803      PMCID: PMC179196          DOI: 10.1128/jb.179.12.3884-3891.1997

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Identification of a multienzyme complex synthesizing fatty acids in the actinomycete Streptomyces erythreus.

Authors:  A Rossi; J W Corcoran
Journal:  Biochem Biophys Res Commun       Date:  1973-02-05       Impact factor: 3.575

3.  A small, discrete acyl carrier protein is involved in de novo fatty acid biosynthesis in Streptomyces erythraeus.

Authors:  R S Hale; K N Jordan; P F Leadlay
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

4.  Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties.

Authors:  H Oishi; T Noto; H Sasaki; K Suzuki; T Hayashi; H Okazaki; K Ando; M Sawada
Journal:  J Antibiot (Tokyo)       Date:  1982-04       Impact factor: 2.649

5.  Thiolactomycin, a new antibiotic. III. In vitro antibacterial activity.

Authors:  T Noto; S Miyakawa; H Oishi; H Endo; H Okazaki
Journal:  J Antibiot (Tokyo)       Date:  1982-04       Impact factor: 2.649

6.  Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli.

Authors:  I Nishida; A Kawaguchi; M Yamada
Journal:  J Biochem       Date:  1986-05       Impact factor: 3.387

7.  Acetoacetyl-acyl carrier protein synthase, a potential regulator of fatty acid biosynthesis in bacteria.

Authors:  S Jackowski; C O Rock
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

8.  Inhibition of fatty acid synthesis by the antibiotic thiolactomycin.

Authors:  T Hayashi; O Yamamoto; H Sasaki; H Okazaki; A Kawaguchi
Journal:  J Antibiot (Tokyo)       Date:  1984-11       Impact factor: 2.649

9.  Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli.

Authors:  T Hayashi; O Yamamoto; H Sasaki; A Kawaguchi; H Okazaki
Journal:  Biochem Biophys Res Commun       Date:  1983-09-30       Impact factor: 3.575

10.  Steric course of deuterium incorporation from [2-2H2]malonyl-CoA into fatty acids by fatty acid synthetases.

Authors:  K Saito; A Kawaguchi; Y Seyama; T Yamakawa; S Okuda
Journal:  J Biochem       Date:  1981-12       Impact factor: 3.387

View more
  6 in total

Review 1.  Recent advances in the chemistry and biology of naturally occurring antibiotics.

Authors:  K C Nicolaou; Jason S Chen; David J Edmonds; Anthony A Estrada
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

2.  Engineered fatty acid biosynthesis in Streptomyces by altered catalytic function of beta-ketoacyl-acyl carrier protein synthase III.

Authors:  N Smirnova; K A Reynolds
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

3.  Role of crotonyl coenzyme A reductase in determining the ratio of polyketides monensin A and monensin B produced by Streptomyces cinnamonensis.

Authors:  H Liu; K A Reynolds
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

4.  Characterization of beta-ketoacyl-acyl carrier protein synthase III from Streptomyces glaucescens and its role in initiation of fatty acid biosynthesis.

Authors:  L Han; S Lobo; K A Reynolds
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

5.  Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering.

Authors:  D L Stassi; S J Kakavas; K A Reynolds; G Gunawardana; S Swanson; D Zeidner; M Jackson; H Liu; A Buko; L Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

6.  Amycomicin is a potent and specific antibiotic discovered with a targeted interaction screen.

Authors:  Gleb Pishchany; Emily Mevers; Sula Ndousse-Fetter; Dennis J Horvath; Camila R Paludo; Eduardo A Silva-Junior; Sergey Koren; Eric P Skaar; Jon Clardy; Roberto Kolter
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-18       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.